Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.

California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major ...

The specialty grocer, which spends millions each year on insulin for employees, accused the companies of profiting from ...

The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.

Sprouts employs approximately 35,000 associates and operates more than 450 stores in 24 states nationwide. The Phoenix-based ...

Californians will be able to buy low-cost, state-branded insulin next year, Gov. Gavin Newsom announced Thursday.

Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...

Insulin resistance was associated with adverse clinical outcomes among patients with PCOS and normal weight undergoing IVF/ICSI.

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s ...

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...

Lawmakers have focused on the high cost of diabetes drugs. The announcement will make state-branded insulin available two ...